Compound ID | 1864
Synonym(s): S-4661
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets.Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases |
Description: | Semisynthetic, derived from thienamycin. Similar to meropenem |
Institute where first reported: | Shionogi Inc |
Year first mentioned: | 2003 |
Highest developmental phase: | Approved by FDA in 2007 |
Development status: | Discontinued |
Reason Dropped: | In treating patients with pneumoniae, doripenem showed increased risk of death and lower clinical cure rates compared to imipenem and cilastatin for injection |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/73303 |
Guide to Pharmacology: | doripenem |
Citations: |
|